Havencrest Healthcare Partners, L.P.'s Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Jan 26, 2024
- Accession no.
- 0000899243-24-000121
- Filed
- Jan 26, 2024, 7:19 PM ET
- Trade date
- Jan 24-26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $96.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Havencrest Healthcare Partners, L.P.CIK 0001705748 | 10% Owner |
| Toi HC I, LLCCIK 0001892154 | 10% Owner |
| Havencrest Healthcare Partners GP, LLCCIK 0001893722 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 24, 2024 | Common stock | SSaleDisposed | −24,915 | $2.30 | −$57,304.5 | 27,498 | Indirect | |
| Jan 25, 2024 | Common stock | SSaleDisposed | −11,882 | $2.07 | −$24,595.74 | 15,616 | Indirect | |
| Jan 26, 2024 | Common stock | SSaleDisposed | −6,979 | $2.14 | −$14,935.06 | 8,637 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.